European Medicines Limited in Worthing, BN11 1TA

Description

Data updated on: 01-11-2023

European Medicines came into being in 2012 as a company enlisted under no 08067182, located at BN11 1TA Worthing at 5 Liverpool Terrace. It has been in business for 12 years and its state is active. This business's classified under the NACE and SIC code 82990 which means Other business support service activities not elsewhere classified. European Medicines Ltd filed its latest accounts for the period up to Fri, 30th Sep 2022. Its latest annual confirmation statement was filed on Thu, 27th Apr 2023.

Taking into consideration this particular enterprise's executives data, since March 2021 there have been three directors: Christian P., Patrick S. and Richard K..

The companies that control the firm are as follows: Medcor Pharmaceuticals B.V. owns over 3/4 of company shares and has 3/4 to full of voting rights. This company can be reached in De Leystad at 8239 and was registered as a PSC under the registration number Chamber Of Commerce 39072043. Richard K. owns 1/2 or less of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-09-30	2022-09-30
Currency

Balance Sheet
Cash Bank On Hand	433 023	291 303	308 463	577 428	952 729	1 791 942	20 771
Current Assets	7 764 710	5 009 232	6 984 295	7 138 123	5 525 561	5 940 493	418 172
Debtors	5 086 776	3 250 306	5 505 792	5 903 906	3 317 013	3 697 317	397 401
Other Debtors	100 839	8 458	25 047	29 304	12 898	15 856
Property Plant Equipment	311	14 058	11 614	6 758	1 903	1 577	1 093
Total Inventories	2 244 911	1 467 623	1 170 040	656 789	1 255 819	451 234

Other Financial Data
Audit Fees Expenses	3 500	3 600	3 650	3 750	3 850	3 950	4 065
Director Remuneration	193 167	198 200	198 400	198 100	198 400	190 838	131 087
Accrued Liabilities Deferred Income	45 464	13 898	47 469	15 942	10 799	54 110	21 528
Accumulated Depreciation Impairment Property Plant Equipment	3 034	5 421	11 151	16 007	20 862	23 125	23 609
Administrative Expenses	814 216	993 061	1 006 008	925 660	899 153	1 074 316	527 743
Amounts Owed By Group Undertakings	313 520	45 058	199 797	138 774	103 375		159 374
Amounts Owed To Group Undertakings	2 041 884	2 518 232	2 870 949	3 119 869	2 214 509	4 120 565	94 986
Applicable Tax Rate	20	20	19	19	19	19	19
Average Number Employees During Period	8	6	7	7	6	6	6
Comprehensive Income Expense	364 946	118 778	-115 796	-163 198	-27 604	19 881	-99 524
Corporation Tax Payable	91 455	26 256
Corporation Tax Recoverable			26 188	26 188
Cost Sales	31 979 334	39 568 655	34 870 836	36 742 695	35 983 407	50 053 339	8 753 758
Creditors	7 194 807	4 334 298	6 422 713	6 734 883	5 145 070	5 539 795	116 514
Current Tax For Period	91 455	26 188
Depreciation Expense Property Plant Equipment	876	2 387	5 730	4 856	4 855	2 263	484
Distribution Costs	225 299	247 954	263 054	239 344	239 249	232 960	66 133
Dividends Paid	176 154
Dividends Paid On Shares Interim	176 154
Finished Goods	2 244 911	1 467 623	1 170 040	656 789	1 255 819	451 234
Further Item Interest Expense Component Total Interest Expense	195 207	203 489	209 274	201 797	191 824	148 785	12 132
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss	23 768	-7 766	-128 186	-77 963	-10 739	-34 428	9 844
Gross Profit Loss	1 691 123	1 589 470	1 336 304	1 203 603	1 265 454	1 520 619	229 776
Increase Decrease In Current Tax From Adjustment For Prior Periods			-26 236
Increase From Depreciation Charge For Year Property Plant Equipment		2 387	5 730	4 856	4 855	2 263	484
Interest Payable Similar Charges Finance Costs	195 207	203 489	209 274	201 797	191 824	190 979	12 132
Net Current Assets Liabilities	569 903	674 934	561 582	403 240	380 491	400 698	301 658
Number Shares Issued But Not Fully Paid		1 000	1 000	1 000	1 000	1 000	1 000
Operating Profit Loss	651 608	348 455	67 242	38 599	127 052	215 524	-107 690
Other Creditors	4 216 728	1 493 425	2 428 626	2 477 559	1 453 258
Par Value Share		1	1	1	1	1	1
Pension Other Post-employment Benefit Costs Other Pension Costs			1 339	3 061	4 381	6 265	4 469
Prepayments	14 219	21 762	27 084	22 744	29 544	28 997	5 004
Profit Loss	364 946	118 778	-115 796	-163 198	-27 604	19 881	-99 524
Profit Loss On Ordinary Activities Before Tax	456 401	144 966	-142 032	-163 198	-64 487	24 545	-119 822
Property Plant Equipment Gross Cost	3 345	19 479	22 765	22 765	22 765	24 702
Social Security Costs	45 121	46 318	43 766	44 615	41 963	48 473	35 072
Staff Costs Employee Benefits Expense	428 883	438 080	411 229	422 157	400 782	497 643	319 388
Tax Decrease From Utilisation Tax Losses			-24 879			4 726
Tax Expense Credit Applicable Tax Rate	91 280	28 993	-26 986	-31 008	-12 253	4 664	-22 766
Tax Increase Decrease From Effect Capital Allowances Depreciation	175	-2 805	420	887	760	62	92
Tax Tax Credit On Profit Or Loss On Ordinary Activities	91 455	26 188	-26 236		-36 883	4 664	-20 298
Total Additions Including From Business Combinations Property Plant Equipment		16 134	3 286			1 937
Total Assets Less Current Liabilities	570 214	688 992	573 196	409 998	382 394	402 275	302 751
Trade Creditors Trade Payables			272 018	632 461	351 573	88 352
Trade Debtors Trade Receivables	4 658 198	3 175 028	5 227 676	5 686 896	3 134 313	3 620 245
Turnover Revenue	33 670 457	41 158 125	36 207 140	37 946 298	37 248 861	51 573 958	8 983 534
Wages Salaries	383 762	391 762	366 124	374 481	354 438	442 905	279 847
Deferred Tax Asset Debtors					36 883	32 219	52 517
Future Minimum Lease Payments Under Non-cancellable Operating Leases							7 901
Other Deferred Tax Expense Credit					-36 883	4 664	-20 298
Other Interest Receivable Similar Income Finance Income					285
Other Operating Income Format1						2 181	256 410
Recoverable Value-added Tax							180 506
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss					6 056		2 469

Company staff

Christian P.

Role: Director

Appointed: 05 March 2021

Latest update: 9 April 2024

Patrick S.

Role: Director

Appointed: 05 March 2021

Latest update: 9 April 2024

Richard K.

Role: Director

Appointed: 14 May 2012

Latest update: 9 April 2024

John C.

Role: Director

Appointed: 20 May 2012

Resigned: 05 March 2021

Latest update: 9 April 2024

Rufus P.

Role: Director

Appointed: 14 May 2012

Resigned: 05 March 2021

Latest update: 9 April 2024

Rufus P.

Role: Secretary

Appointed: 14 May 2012

Resigned: 05 March 2021

Latest update: 9 April 2024

Stuart O.

Role: Director

Appointed: 14 May 2012

Resigned: 16 November 2020

Latest update: 9 April 2024

People with significant control

Medcor Pharmaceuticals B.V.

Address: Artemisweg 232 8239, De Leystad, Netherlands

Legal authority Dutch Civil Code

Legal form Private Limited Company

Country registered Netherlands

Place registered Dutch Trade Register Of The Chamber Of Commerce

Registration number Chamber Of Commerce 39072043

Notified on 5 March 2021

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Richard K.

Notified on 6 April 2016

Nature of control:

1/2 or less of shares

Munro Healthcare Group Limited

Address: 3 Young Place, East Kilbride, Glasgow, G75 0TD

Legal authority Scotland

Legal form Private Limited Company

Country registered Scotland

Place registered Registrar Of Companies (Scotland)

Registration number Sc417011

Notified on 6 April 2016

Ceased on 5 March 2021

Nature of control:

over 1/2 to 3/4 of shares

over 1/2 to 3/4 of voting rights

Accounts Documents

Account next due date	30 June 2024
Account last made up date	30 September 2022
Confirmation statement next due date	11 May 2024
Confirmation statement last made up date	27 April 2023

Annual Accounts
Start Date For Period Covered By Report	01 April 2016
End Date For Period Covered By Report	31 March 2017
Annual Accounts
Start Date For Period Covered By Report	01 April 2017
End Date For Period Covered By Report	31 March 2018
Annual Accounts
Start Date For Period Covered By Report	01 April 2018
End Date For Period Covered By Report	31 March 2019
Annual Accounts
Start Date For Period Covered By Report	01 April 2019
End Date For Period Covered By Report	31 March 2020
Annual Accounts
Start Date For Period Covered By Report	01 April 2020
End Date For Period Covered By Report	30 September 2021
Annual Accounts
Start Date For Period Covered By Report	01 October 2021
End Date For Period Covered By Report	30 September 2022

European Medicines Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Christian P.

Patrick S.

Richard K.

John C.

Rufus P.

Rufus P.

Stuart O.

People with significant control

Medcor Pharmaceuticals B.V.

Richard K.

Munro Healthcare Group Limited

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies